Page last updated: 2024-08-18

pyrroles and Diabetes Mellitus

pyrroles has been researched along with Diabetes Mellitus in 101 studies

Research

Studies (101)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (15.84)	18.7374
1990's	8 (7.92)	18.2507
2000's	35 (34.65)	29.6817
2010's	34 (33.66)	24.3611
2020's	8 (7.92)	2.80

Authors

Authors	Studies
Fan, L; Guan, P; Li, Y; Liu, C; Luo, Y; Ning, C; Tan, G; Wang, Q; Wen, H; Xiao, C; Yu, P; Zhou, L; Zou, Y	1
Chen, C; Chen, J; Chen, Z; Deng, Y; Guo, H; Huang, H; Li, G; Liu, J; Liu, N; Sai, X; Sun, T; Wang, X; Yu, C; Zhao, M; Zheng, Y; Zhu, P; Zhu, S; Zhuang, J	1
Che, S; Feng, Y; Guan, L; Li, Z; Lin, Q; Liu, H; Wang, J; Yang, B; Yang, X; Zhao, Y; Zvyagin, AV	1
Akasaka, T; Hashimoto, M; Hosoya, T; Komoto, K; Murakami, K; Nakajima, H; Nakamura, A; Nunoue, T; Shiosakai, K; Sugimoto, K; Taguchi, T; Uchida, HA; Wada, J	1
Chen, X; Guo, Z; Jiang, Z; Liang, Z; Liu, J; Liu, W; Nie, L; Ren, X; Spencer, P; Wu, D; Wu, Y; Yang, X; Zhang, L	1
Fan, D; He, L; Li, G; Liang, W; Lin, Z; Qin, X; Wang, Q; Zhao, B	1
Chhina, RS; Goyal, O; Goyal, P	1
Chen, X; Feng, W; Guo, Z; He, K; Lin, D; Liu, J; Liu, W; Nie, L; Spencer, P; Wang, L; Yang, X; Yuan, J; Zhu, F	1
Cheng, XC; Feng, XY; Jia, WQ; Jing, Z; Liu, JW; Liu, X; Liu, YY; Wang, SQ; Xu, WR	1
Li, H; Yu, SJ	1
Shah, SN	1
Coates, LC; Deal, C; Deodhar, A; Dubreuil, M; Dunham, J; Gladman, DD; Gottlieb, A; Guyatt, G; Husni, ME; Jonsson, AH; Kenny, S; Kwan-Morley, J; Lin, J; Magrey, M; Marchetta, P; Mease, PJ; Merola, JF; Miner, J; Nowell, WB; Ogdie, A; Orbai, AM; Reddy, SM; Reston, J; Ritchlin, CT; Scher, JU; Shah, AA; Siaton, B; Siegel, E; Siegel, M; Singh, JA; Smith, BJ; Sullivan, N; Turgunbaev, M; Turner, AS; Van Voorhees, AS; Walsh, JA	1
Long, M; Zhou, SW	1
Brimble, MA; Cooper, GJ; Woods, TM	1
Campbell, SM; Godman, B; Gustafsson, LL; Pichetti, S; Sermet, C	1
Abbate, R; Angiolillo, DJ; Bellandi, F; Giusti, B; Leoncini, M; Maioli, M; Marcucci, R; Toso, A	1
Aksoy, Y; Senen, K; Sivri, N; Tekin, G; Yalta, K; Yetkin, E	1
Ahn, CW; Cha, BS; Cho, Y; Choe, EY; Huh, KH; Kang, ES; Kim, MS; Kim, YS; Kwon, O; Lee, HC; Wang, HJ	1
Barter, PJ; DeMicco, DA; Messig, M; Ong, KL; Rye, KA; Waters, DD	1
Cho, EJ; Kim, JH; Sutradhar, S; Westergaard, M; Yunis, C	1
Budoff, M; Folse, HJ; Goswami, D; Kahn, R; Rengarajan, B	1
Jinnouchi, H; Masuda, I; Matsui, K; Mori, H; Ogawa, H; Saito, Y; Sugawara, M; Sugiyama, S; Waki, M; Watada, H; Yoshiyama, M	1
Ballantyne, CM; Barter, PJ; Chapman, MJ; Cho, L; Erbel, R; Kataoka, Y; Libby, P; Nicholls, SJ; Nissen, SE; Puri, R; Raichlen, JS; Shao, M; Stegman, B; Uno, K	1
Ahn, CW; Cha, BS; Cho, Y; Choe, E; Choi, Y; Kang, ES; Lee, HC; Lee, YH; Seo, JW; Wang, HJ; Yun, Y	1
Berger, R; Carducci, MA; Eisenberger, MA; Gottfried, M; Hammers, H; Ish-Shalom, M; Keizman, D; Maimon, N; Mermershtain, W; Neiman, V; Peer, A; Rosenbaum, E; Rouvinov, K; Sarid, D; Sella, A; Sinibaldi, V	1
Kelwade, J; Nagesh, VS; Sethi, BK; Vaseem, A	1
Deedwania, P; Singh, V	1
Benner, JS; Foody, JM; Jeffers, BW; Joyce, AT; Liu, LZ	1
Cziraky, M; Grochulski, D; Hoy, T; Jacobson, TA; Kuznik, A; Wertz, DA	1
Clementi, F; Di Luozzo, M; Luciani, G; Mango, R; Martuscelli, E; Mehta, JL; Pizzuto, F; Romeo, F; Trivisonno, A	1
Kishi, T; Okamatsu, S; Sunagawa, K; Yamada, A	1
Blann, AD; Goon, PK; Jaumdally, RJ; Lip, GY; Varma, C	1
Abate, N; Ballantyne, CM; Catapano, AL; Davidson, MH; Polis, AB; Smugar, SS; Tershakovec, AM	1
Tasci, I	1
Daida, H; Hiro, T; Kimura, K; Kimura, T; Matsuzaki, M; Miyauchi, K; Morimoto, T; Nakagawa, Y; Ozaki, Y; Saito, S; Yamagishi, M; Yamaguchi, T	1
Arai, H; Daida, H; Hiro, T; Kimura, K; Kimura, T; Matsuzaki, M; Miyauchi, K; Morimoto, T; Nakagawa, Y; Ozaki, Y; Saito, S; Yamagishi, M; Yamaguchi, T	1
Agostino, NM; Chinchilli, VM; Drabick, JJ; Gingrich, R; Koszyk-Szewczyk, A; Lynch, CJ; Sivik, J	1
Birnbaum, H; Ivanova, J; Kuznik, A; Ramakrishnan, K; Signorovitch, J; Simpson, RJ	1
Ai, M; Asztalos, BF; Himbergen, TV; Jones, PH; Nakajima, K; Otokozawa, S; Schaefer, EJ; Stein, E; Thongtang, N	1
Blann, AD; Jaumdally, RJ; Lip, GY; Varma, C	1
Cap, M; Devasthale, P; Egan, D; Fura, A; Hamann, LG; Harrity, T; Kirby, MS; Kish, K; Klei, HE; Levesque, P; Li, YX; Morgan, N; Sun, L; Wang, A; Wang, W; Weigelt, C; Zahler, R	1
Achimastos, A; Alexandrides, T; Athyros, VG; Bilianou, E; Elisaf, MS; Ganotakis, E; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP; Tziomalos, K	1
Chan, WC; Hopkins, R; Jackson, G; Lawes, CM; Marshall, R; Thornley, S; Young, R	1
Byun, SS; Hong, SK; Joo, YM; Lee, BK; Lee, S; Lee, SE; Min, SH; Oh, JJ	1
Arslan, F; Cete, S; Colak, O; Yaşar, A	1
Barter, PJ; Karlson, BW; Lundman, P; Nicholls, SJ; Palmer, MK	1
Akhlaghi, F; Dostalek, M; Gohh, RY; Macwan, JS; Paryani, KR; Sam, WJ	1
Al-Khadra, A; Erdine, S; Kim, JH; Pavia, A; Sutradhar, S; Yunis, C; Zamorano, J	1
Demopoulos, VJ; Nicolaou, I	1
Ravnskov, U	1
Ceska, R; Kasalová, Z; Prázný, M; Skrha, J; Stulc, T; Vrablík, M	1
COLLINS, A; HELLMAN, ES; HUNTER, GW; TSCHUDY, DP; WELLAND, FH	1
Philips, JC; Radermecker, RP; Scheen, AJ	1
Klose, G	1
Ganda, OP	1
McFarlane, SI; Murad, O; Palmer, J; Sowers, J	1
Athyros, VG; Didangelos, TP; Elisaf, M; Kakafika, AI; Karagiannis, A; Kleta, D; Mikhailidis, DP; Papageorgiou, AA; Peletidou, A; Tziomalos, K	1
Ichihara, K; Kanda, M; Kasai, T; Keimatsu, N; Satoh, K; Sun, F; Takaguri, A	1
Davidson, MH	1
Fukazawa, M; Ishikawa, M; Kubota, T; Moroi, M; Namiki, A; Sugi, K; Yajima, S	1
Dincer, I; Erol, C; Ertas, F; Ongun, A; Ozdol, C; Turhan, S	1
Anraku, M; Kitamura, K; Maruyama, T; Mera, K; Nakajou, K; Otagiri, M; Tomita, K	1
Iwashita, M; Kono, S; Sasaki, J	1
Gennimata, V; Ikonomidis, I; Kotsis, V; Lekakis, J; Pitiriga, V; Protogerou, A; Zakopoulos, N	1
Blanco-Colio, LM; de Teresa, E; Egido, J; Farsang, C; Gaw, A; Gensini, G; Hérnandez, G; Langer, A; Leiter, LA; Martín-Ventura, JL; Martineau, P	1
Nesto, RW; Singh, PP	1
Aretini, A; Gentile, MT; Landolfi, A; Lembo, G; Maffei, A; Marino, G; Passarelli, F; Poulet, R; Vasta, A; Vecchione, C	1
Botteman, MF; Damen, J; Koren, MJ; Kuntze, CE; Liu, LZ; Mamdani, M; Straka, RJ	1
Shaley, FM	1
Athyros, VG; Kakafika, AI; Karagiannis, A; Koumaras, H; Mikhailidis, DP; Tziomalos, K	1
Bybee, KA; Lee, JH; O'Keefe, JH	1
Ishiguro, I; Ito, M; Matsuzawa, T	1
Felten, DL; Holland, ML; Moore, SA; Novotny, M; Peterson, RG; Rhodes, G; Wiesler, D	1
Monnier, VM; Nagaraj, RH	1
Monnier, VM; Nagaraj, RH; Portero-Otin, M	2
Benn, J; Smith, PR; Somani, HH; Sonksen, PH; Thornalley, PJ	1
Nagaraj, RH; Sady, C	1
Bailey, AJ; Paul, RG	1
Ahmed, MU; Baynes, JW; Brinkmann, E; Litchfield, JE; Reddy, S; Thorpe, SR; Wells-Knecht, KJ; Wells-Knecht, MC; Zyzak, DV	1
Kamei, J; Ohsawa, M	1
Arnaboldi, L; Bellosta, S; Bernini, F; Corsini, A; Ferri, N; Paoletti, R	1
DiTusa, L; Luzier, AB	1
Chan, E; Charles, MA; Pan, J; Van, JT; Wasty, T; Wu, X	1
Berk-Planken, I; de Konig, I; Hoogerbrugge, N; Jansen, H; Stolk, R	1
Chlud, K; Kaik, B	1
Al-Babbili, O; Liebich, HM	1
Liebich, HM	1
Vainer, H; Verry, M	1
Dechavanne, M; Desnoyers, P; Stoltz, JF; Vainer, H; Verry, M	1
Riveline, B	1
Plauchu, M; Pousset, G	1
Masbernard, A; Portal, A	1
Simonin, R	1
Desnoyers, P; Verry, M	1
Bour, H; Denard, Y; Plauchu, M; Rathery, M; Simonin, R; Thervet, F; Warembourg, H	1
Chittenden, M; Lewis, N; Padron, JL	1

Reviews

11 review(s) available for pyrroles and Diabetes Mellitus

Article	Year
Review of pentosidine and pyrraline in food and chemical models: formation, potential risks and determination. Journal of the science of food and agriculture, 2018, Volume: 98, Issue:9 Topics: Arginine; Cross-Linking Reagents; Diabetes Complications; Diabetes Mellitus; Food Analysis; Glucose; Glycation End Products, Advanced; Humans; Inflammation; Lysine; Molecular Structure; Norleucine; Pyrroles; Risk Factors; Uremia	2018
[Advances in the studies of glycogen synthase kinase-3 and diabetes]. Sheng li ke xue jin zhan [Progress in physiology], 2012, Volume: 43, Issue:6 Topics: Animals; Azepines; Diabetes Mellitus; Glucose; Glycogen Synthase Kinase 3; Humans; Pyrroles	2012
Expanding roles for atorvastatin. Drugs of today (Barcelona, Spain : 1998), 2008, Volume: 44, Issue:6 Topics: Atorvastatin; Clinical Trials as Topic; Diabetes Mellitus; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Metabolic Syndrome; Pyrroles; Renal Insufficiency; Stroke	2008
Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2012, Volume: 22, Issue:9 Topics: Adolescent; Adult; Aged; Atorvastatin; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Databases, Factual; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Triglycerides; Young Adult	2012
The role of lipid management in diabetes. Cardiology clinics, 2005, Volume: 23, Issue:2 Topics: Anticholesteremic Agents; Atorvastatin; Diabetes Mellitus; Diabetic Angiopathies; Gemfibrozil; Heptanoic Acids; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, HDL; Pyrroles; Simvastatin; Triglycerides	2005
Statins and CVD prevention in the diabetic population: implications of the CARDS trial. Current diabetes reports, 2005, Volume: 5, Issue:3 Topics: Atorvastatin; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Survival Analysis	2005
Reducing residual risk for patients on statin therapy: the potential role of combination therapy. The American journal of cardiology, 2005, Nov-07, Volume: 96, Issue:9A Topics: Atorvastatin; Cholesterol, LDL; Coronary Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Pyrroles; Risk Factors	2005
Statins: beneficial or adverse for glucose metabolism. Journal of atherosclerosis and thrombosis, 2006, Volume: 13, Issue:3 Topics: Atorvastatin; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pyrroles	2006
Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. Current medical research and opinion, 2008, Volume: 24, Issue:4 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Heptanoic Acids; Humans; Kidney Failure, Chronic; Pyrroles; Risk Factors; Stroke	2008
Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. The international journal of biochemistry & cell biology, 1996, Volume: 28, Issue:12 Topics: Aging; Animals; Arginine; Collagen; Cross-Linking Reagents; Diabetes Complications; Diabetes Mellitus; Elastin; Glycation End Products, Advanced; Glycosylation; Humans; Imidazoles; Lysine; Maillard Reaction; Malondialdehyde; Norleucine; Pyrroles	1996
New biomarkers of Maillard reaction damage to proteins. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11 Suppl 5 Topics: Aging; Arginine; Biomarkers; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Glycosylation; Humans; Lysine; Maillard Reaction; Molecular Structure; Norleucine; Oxidation-Reduction; Proteins; Pyrroles	1996

Trials

18 trial(s) available for pyrroles and Diabetes Mellitus

Article	Year
Pharmacodynamic effects of adjunctive high dose atorvastatin on double dose clopidogrel in patients with high on-treatment platelet reactivity depending on diabetes mellitus status. Journal of thrombosis and thrombolysis, 2014, Volume: 37, Issue:4 Topics: Aged; Atorvastatin; Clopidogrel; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Thrombosis; Ticlopidine	2014
Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study). The American journal of cardiology, 2014, May-15, Volume: 113, Issue:10 Topics: Atorvastatin; Body Weight; Coronary Artery Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Global Health; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Life Style; Male; Middle Aged; Pyrroles; Risk Factors; Time Factors; Weight Loss	2014
Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis. Vascular health and risk management, 2014, Volume: 10 Topics: Aged; Amlodipine; Antihypertensive Agents; Asia; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus; Drug Combinations; Dyslipidemias; Europe; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Latin America; Male; Middle Aged; Middle East; Preventive Health Services; Prospective Studies; Pyrroles; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2014
Differences between rosuvastatin and atorvastatin in lipid-lowering action and effect on glucose metabolism in Japanese hypercholesterolemic patients with concurrent diabetes. Lipid-lowering with highly potent statins in hyperlipidemia with type 2 diabete Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:10 Topics: Asian People; Atorvastatin; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Follow-Up Studies; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Japan; Male; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides	2014
High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes care, 2014, Volume: 37, Issue:11 Topics: Aged; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Ultrasonography, Interventional	2014
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk Metabolic syndrome and related disorders, 2009, Volume: 7, Issue:6 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Coronary Disease; Diabetes Mellitus; Double-Blind Method; Drug Combinations; Ezetimibe, Simvastatin Drug Combination; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Pyrimidines; Pyrroles; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2009
Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acut Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:6 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Coronary Artery Disease; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Quinolines; Treatment Outcome; Ultrasonography, Interventional	2010
More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study. Journal of atherosclerosis and thrombosis, 2010, Oct-27, Volume: 17, Issue:10 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Middle Aged; Prospective Studies; Pyrroles; Quinolines; Treatment Outcome; Ultrasonography, Interventional	2010
Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. The American journal of cardiology, 2011, Feb-01, Volume: 107, Issue:3 Topics: Adiponectin; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Diabetes Mellitus; Female; Fluorobenzenes; Glucose; Glycated Serum Albumin; Glycation End Products, Advanced; Heptanoic Acids; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Insulin; Male; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Serum Albumin; Sulfonamides; Triglycerides	2011
Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology, 2012, Volume: 63, Issue:5 Topics: Aged; Atorvastatin; Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Diabetes Mellitus; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Metabolic Syndrome; Middle Aged; Prospective Studies; Pyrroles; Risk Assessment; Risk Factors; Risk Reduction Behavior; Time Factors; Treatment Outcome	2012
Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes. Clinical pharmacokinetics, 2012, Sep-01, Volume: 51, Issue:9 Topics: Adult; Atorvastatin; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Transplantation; Male; Metabolic Clearance Rate; Microsomes, Liver; Middle Aged; Models, Biological; Pyrroles	2012
Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis. Postgraduate medicine, 2012, Volume: 124, Issue:4 Topics: Adult; Aged; Amlodipine; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Lipids; Male; Middle Aged; Pyrroles; Risk Factors; Risk Management; Treatment Outcome	2012
Targeting vascular risk in patients with metabolic syndrome but without diabetes. Metabolism: clinical and experimental, 2005, Volume: 54, Issue:8 Topics: Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Diabetes Mellitus; Drug Therapy, Combination; Female; Fenofibrate; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Metabolic Syndrome; Middle Aged; Obesity; Prevalence; Prospective Studies; Pyrroles; Risk Factors; Risk Reduction Behavior	2005
Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST. Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:1 Topics: Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Dose-Response Relationship, Drug; Fas Ligand Protein; fas Receptor; Female; Gene Expression Regulation; Heptanoic Acids; Humans; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Pyrroles; Risk Factors	2007
Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. The American journal of cardiology, 2008, Feb-15, Volume: 101, Issue:4 Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Coronary Artery Disease; Creatinine; Diabetes Mellitus; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Pyrroles; Stroke	2008
Atorvastatin, diabetic dyslipidemia, and cognitive functioning. Diabetes care, 2002, Volume: 25, Issue:7 Topics: Aged; Atorvastatin; Cholesterol; Cognition; Diabetes Complications; Diabetes Mellitus; Fasting; Heptanoic Acids; Humans; Hyperlipidemias; Middle Aged; Pyrroles; Time Factors; Triglycerides	2002
Clinical studies of the interaction between tolmetin and glibenclamide. International journal of clinical pharmacology and biopharmacy, 1977, Volume: 15, Issue:9 Topics: Adult; Aged; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Drug Interactions; Female; Glyburide; Glycosuria; Humans; Middle Aged; Pyrroles; Rheumatic Diseases; Time Factors; Tolmetin	1977
[Long term study of a new antidiabetic agent in 1183 cases]. Semaine des hopitaux. Therapeutique, 1974, Volume: 50, Issue:2 Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Drug Evaluation; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrroles; Sulfonylurea Compounds	1974

Other Studies

72 other study(ies) available for pyrroles and Diabetes Mellitus

Article	Year
Extracellular Matrix-Based Conductive Interpenetrating Network Hydrogels with Enhanced Neurovascular Regeneration Properties for Diabetic Wounds Repair. Advanced healthcare materials, 2022, Volume: 11, Issue:1 Topics: Diabetes Mellitus; Electric Conductivity; Extracellular Matrix; Gelatin; Humans; Hydrogels; Methacrylates; Phosphatidylinositol 3-Kinases; Polymers; Pyrroles	2022
Histatin-1 loaded multifunctional, adhesive and conductive biomolecular hydrogel to treat diabetic wound. International journal of biological macromolecules, 2022, Jun-01, Volume: 209, Issue:Pt A Topics: Adhesives; Diabetes Mellitus; Gelatin; Histatins; Humans; Hydrogels; Inflammation; Polymers; Pyrroles; Wound Healing	2022
A smart hydrogel patch with high transparency, adhesiveness and hemostasis for all-round treatment and glucose monitoring of diabetic foot ulcers. Journal of materials chemistry. B, 2022, 08-04, Volume: 10, Issue:30 Topics: Adhesiveness; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus; Diabetic Foot; Hemostasis; Humans; Hydrogels; Polymers; Pyrroles	2022
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study. Advances in therapy, 2022, Volume: 39, Issue:11 Topics: Albumins; Albuminuria; Blood Pressure; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Hypertension; Potassium; Prospective Studies; Pyrroles; Sulfones	2022
Protein pyrrole adducts are associated with elevated glucose indices and clinical features of diabetic diffuse neuropathies. Journal of diabetes, 2022, Volume: 14, Issue:10 Topics: Aged; Blood Glucose; China; Diabetes Mellitus; Diabetic Neuropathies; Glucose; Humans; Middle Aged; Pyrroles	2022
Antibacterial, Adhesive, and Conductive Hydrogel for Diabetic Wound Healing. Macromolecular bioscience, 2023, Volume: 23, Issue:2 Topics: Adhesives; Anti-Bacterial Agents; Diabetes Mellitus; Electric Conductivity; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogels; Metal Nanoparticles; Polymers; Pyrroles; Silver; Wound Healing	2023
Saroglitazar Improves Transaminases and Elastography in Patients with Diabetic Dyslipidemia and Non-Alcoholic Fatty Liver Disease. The Journal of the Association of Physicians of India, 2020, Volume: 68, Issue:1 Topics: Diabetes Mellitus; Dyslipidemias; Elasticity Imaging Techniques; Humans; Liver; Non-alcoholic Fatty Liver Disease; Phenylpropionates; Pyrroles; Transaminases	2020
Diabetes mellitus is associated with elevated urinary pyrrole markers of γ-diketones known to cause axonal neuropathy. BMJ open diabetes research & care, 2020, Volume: 8, Issue:1 Topics: Aged; Aged, 80 and over; Axons; China; Diabetes Mellitus; Humans; Middle Aged; Peripheral Nervous System Diseases; Pyrroles	2020
Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar. Journal of biomolecular structure & dynamics, 2018, Volume: 36, Issue:13 Topics: Diabetes Mellitus; Drug Discovery; Dyslipidemias; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Molecular Dynamics Simulation; Phenylpropionates; PPAR alpha; PPAR gamma; Pyrroles	2018
The Road to Preventing Diabetes: Addressing Prediabetes and Concomitant Dyslipidemia. The Journal of the Association of Physicians of India, 2018, Volume: 66, Issue:3 Topics: Diabetes Mellitus; Dyslipidemias; Humans; Phenylpropionates; Prediabetic State; Pyrroles	2018
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:1 Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Comorbidity; Diabetes Mellitus; Enthesopathy; Etanercept; Evidence-Based Medicine; Exercise; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Interleukin-12; Interleukin-17; Interleukin-23; Occupational Therapy; Physical Therapy Modalities; Piperidines; Pyrimidines; Pyrroles; Rheumatology; Smoking Cessation; Societies, Medical; Spondylitis; Tumor Necrosis Factor-alpha; Ustekinumab; Weight Loss	2019
Synthesis of stable isotope-labelled monolysyl advanced glycation endproducts. Amino acids, 2013, Volume: 45, Issue:2 Topics: Diabetes Mellitus; Glycation End Products, Advanced; Isotope Labeling; Lysine; Mass Spectrometry; Norleucine; Pyrroles	2013
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France. Applied health economics and health policy, 2013, Volume: 11, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atorvastatin; Diabetes Mellitus; Drug Prescriptions; Drugs, Generic; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; France; General Practitioners; Heart Diseases; Heptanoic Acids; Humans; Indoles; Lipid Metabolism Disorders; Male; Middle Aged; Models, Statistical; Practice Patterns, Physicians'; Pravastatin; Prescription Drugs; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2013
Statins decrease mean platelet volume irrespective of cholesterol lowering effect. Kardiologia polska, 2013, Volume: 71, Issue:10 Topics: Adult; Atorvastatin; Cholesterol, LDL; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Hypertension; Male; Mean Platelet Volume; Middle Aged; Pyrimidines; Pyrroles; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides	2013
HMG CoA reductase inhibitor treatment induces dysglycemia in renal allograft recipients. Transplantation, 2014, Feb-27, Volume: 97, Issue:4 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Dyslipidemias; Fasting; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Immunosuppressive Agents; Incidence; Indoles; Kidney Transplantation; Male; Middle Aged; Pyrroles; Renal Insufficiency	2014
Clinical- and cost-effectiveness of LDL particle-guided statin therapy: a simulation study. Atherosclerosis, 2014, Volume: 236, Issue:1 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Comorbidity; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Diabetes Mellitus; Drug Costs; Drug Substitution; Dyslipidemias; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Life Style; Lipoproteins, LDL; Medicare; Models, Cardiovascular; Nuclear Magnetic Resonance, Biomolecular; Pyrroles; Quality-Adjusted Life Years; Risk; Risk Reduction Behavior; Simvastatin; Treatment Outcome; United States	2014
Risk of diabetes in patients treated with HMG-CoA reductase inhibitors. Metabolism: clinical and experimental, 2015, Volume: 64, Issue:4 Topics: Aged; Atorvastatin; Diabetes Mellitus; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Pyrimidines; Pyrroles; Quinolines; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2015
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma. Clinical genitourinary cancer, 2016, Volume: 14, Issue:5 Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Comorbidity; Diabetes Mellitus; Disease-Free Survival; Female; Humans; Indoles; Kidney Neoplasms; Male; Metformin; Middle Aged; Neoplasm Metastasis; Proportional Hazards Models; Pyrroles; Retrospective Studies; Sunitinib; Treatment Outcome	2016
Unique Interaction of Saroglitazar with Insulin. The Journal of the Association of Physicians of India, 2015, Volume: 63, Issue:12 Topics: Blood Glucose; Diabetes Mellitus; Drug Interactions; Female; Humans; Hypertriglyceridemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Middle Aged; Phenylpropionates; PPAR alpha; PPAR gamma; Pyrroles	2015
A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease. Diabetes research and clinical practice, 2008, Volume: 82, Issue:1 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus; Health Maintenance Organizations; Heptanoic Acids; Humans; Preferred Provider Organizations; Pyrroles; Simvastatin; Treatment Outcome; United States	2008
Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiated. Mayo Clinic proceedings, 2008, Volume: 83, Issue:12 Topics: Adolescent; Adult; Atorvastatin; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Primary Prevention; Proportional Hazards Models; Pyrroles; Retrospective Studies; Risk; Simvastatin; United States	2008
Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis. Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:3 Topics: Aged; Atorvastatin; Calcinosis; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Female; Fibrosis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Middle Aged; Necrosis; Pilot Projects; Pioglitazone; Prospective Studies; Pyrroles; Registries; Thiazolidinediones; Time Factors; Treatment Outcome; Ultrasonography, Interventional; User-Computer Interface	2009
Atorvastatin might improve ventricular electrostability and decelerate the deterioration of renal function in patients with heart failure and diabetes mellitus. Journal of cardiology, 2009, Volume: 53, Issue:3 Topics: Aged; Atorvastatin; Diabetes Mellitus; Female; Glomerular Filtration Rate; Heart Failure; Heart Ventricles; Heptanoic Acids; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Pyrroles; Retrospective Studies; Ventricular Premature Complexes	2009
Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. Journal of internal medicine, 2010, Volume: 267, Issue:4 Topics: Aged; Angiopoietin-1; Angiopoietin-2; Antigens, CD; Antigens, CD34; Atherosclerosis; Atorvastatin; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Common Antigens; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Pyrroles; Stem Cells; Vascular Endothelial Growth Factor A	2010
Clinical usefulness of AGEs as a biomarker for the attenuation of NASH. Journal of gastroenterology, 2010, Volume: 45, Issue:7 Topics: Anticholesteremic Agents; Atorvastatin; Biomarkers; Diabetes Mellitus; Fatty Liver; Glycation End Products, Advanced; Heptanoic Acids; Humans; Hypertension; Pyrroles	2010
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:3 Topics: Aged; Antineoplastic Agents; Benzamides; Benzenesulfonates; Blood Glucose; Dasatinib; Diabetes Mellitus; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Imatinib Mesylate; Indoles; Linear Models; Male; Middle Aged; Neoplasms; Niacinamide; Pennsylvania; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Sorafenib; Sunitinib; Thiazoles; Time Factors; Treatment Outcome	2011
Cardiovascular and economic outcomes after initiation of atorvastatin versus simvastatin in an employed population stratified by cardiovascular risk. American journal of therapeutics, 2011, Volume: 18, Issue:6 Topics: Absenteeism; Adult; Atorvastatin; Cardiovascular Diseases; Cohort Studies; Cost-Benefit Analysis; Diabetes Mellitus; Drug Costs; Employment; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Risk; Simvastatin	2011
Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes. Angiology, 2011, Volume: 62, Issue:7 Topics: Adult; Aged; Angiogenic Proteins; Asian People; Atorvastatin; Cardiovascular Diseases; Case-Control Studies; CD40 Ligand; Diabetes Mellitus; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; P-Selectin; Pyrroles; von Willebrand Factor; White People	2011
7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site. Bioorganic & medicinal chemistry letters, 2011, Nov-15, Volume: 21, Issue:22 Topics: Animals; Catalytic Domain; Cytochrome P-450 CYP3A; Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Ether-A-Go-Go Potassium Channels; Humans; Insulin; Mice; Mice, Inbred C57BL; Models, Molecular; Pyridines; Pyrroles; Rats; Stereoisomerism	2011
Statin use in COPD patients is associated with a reduction in mortality: a national cohort study. Primary care respiratory journal : journal of the General Practice Airways Group, 2012, Volume: 21, Issue:1 Topics: Aged; Atorvastatin; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medical Record Linkage; Middle Aged; New Zealand; Pulmonary Disease, Chronic Obstructive; Pyrroles; Simvastatin; Treatment Outcome	2012
Impact of sunitinib treatment on blood glucose levels in patients with metastatic renal cell carcinoma. Japanese journal of clinical oncology, 2012, Volume: 42, Issue:4 Topics: Aged; Angiogenesis Inhibitors; Blood Glucose; Carcinoma, Renal Cell; Diabetes Mellitus; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib	2012
Glucose biosensor based on the immobilization of glucose oxidase on electrochemically synthesized polypyrrole-poly(vinyl sulphonate) composite film by cross-linking with glutaraldehyde. Artificial cells, blood substitutes, and immobilization biotechnology, 2012, Volume: 40, Issue:5 Topics: Biosensing Techniques; Blood Glucose; Cross-Linking Reagents; Diabetes Mellitus; Electrochemical Techniques; Enzymes, Immobilized; Glucose Oxidase; Glutaral; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Oxidation-Reduction; Platinum; Polymers; Polyvinyls; Pyrroles; Sulfonic Acids; Temperature	2012
Substituted pyrrol-1-ylacetic acids that combine aldose reductase enzyme inhibitory activity and ability to prevent the nonenzymatic irreversible modification of proteins from monosaccharides. Journal of medicinal chemistry, 2003, Jan-30, Volume: 46, Issue:3 Topics: Acetates; Aldehyde Reductase; Animals; Diabetes Mellitus; Enzyme Inhibitors; Female; Fructose; Male; Monosaccharides; Oxidation-Reduction; Proteins; Pyrroles; Rats; Rats, Inbred F344; Serum Albumin; Structure-Activity Relationship	2003
ASCOT-LLA: questions about the benefits of atorvastatin. Lancet (London, England), 2003, Jun-07, Volume: 361, Issue:9373 Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Neoplasms; Pyrroles	2003
Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatment. Physiological research, 2003, Volume: 52, Issue:4 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Blood Component Removal; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hyperemia; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Pilot Projects; Pyrroles; Skin	2003
Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins. Prescrire international, 2003, Volume: 12, Issue:66 Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus; Drug Evaluation; Heptanoic Acids; Humans; Hypertension; Pravastatin; Pyrroles; Rhabdomyolysis; Simvastatin; Stroke; Treatment Outcome	2003
FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. II. THE EFFECT OF ETHINYL ESTRADIOL. Metabolism: clinical and experimental, 1964, Volume: 13 Topics: Amino Acids; Diabetes Mellitus; Ethinyl Estradiol; Humans; Levulinic Acids; Medroxyprogesterone; Metabolism; Pharmacology; Porphyria, Acute Intermittent; Porphyrias; Porphyrins; Pyrroles; Urine	1964
[Optimizing the managment of patients with diabetes mellitus: selected clinical trials from the 2004 Congress of the American Diabetes Association]. Revue medicale de Liege, 2004, Volume: 59, Issue:6 Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Exenatide; Glucagon; Glucagon-Like Peptide 1; Heptanoic Acids; Humans; Islets of Langerhans Transplantation; Peptide Fragments; Peptides; Protein Precursors; Pyrroles; Venoms	2004
[Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?]. MMW Fortschritte der Medizin, 2004, Jun-24, Volume: 146, Issue:26 Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Diabetes Mellitus; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Long-Term Care; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome	2004
[To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too]. MMW Fortschritte der Medizin, 2005, Aug-18, Volume: 147, Issue:33-34 Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Coronary Disease; Diabetes Mellitus; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Placebos; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Triglycerides	2005
[Considerable LDL lowering is advantageous]. MMW Fortschritte der Medizin, 2005, Sep-01, Volume: 147, Issue:35-36 Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Controlled Clinical Trials as Topic; Diabetes Mellitus; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Placebos; Pyrroles; Risk; Risk Factors; Triglycerides	2005
HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats. Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:11 Topics: Animals; Atorvastatin; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Glucose Intolerance; Glucose Tolerance Test; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Pravastatin; Pyrroles; Rats; Rats, Wistar; Simvastatin	2005
Effect of pravastatin and atorvastatin on glucose metabolism in nondiabetic patients with hypercholesterolemia. Internal medicine (Tokyo, Japan), 2006, Volume: 45, Issue:2 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Carbohydrate Metabolism; Diabetes Mellitus; Female; Glucose; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipid Metabolism; Male; Pravastatin; Pyrroles; Retrospective Studies; Treatment Outcome	2006
Effect of statin treatment on coronary collateral development in patients with diabetes mellitus. The American journal of cardiology, 2006, Mar-15, Volume: 97, Issue:6 Topics: Angina Pectoris; Atorvastatin; Cholesterol, LDL; Collateral Circulation; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pravastatin; Pyrroles; Retrospective Studies; Simvastatin	2006
Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Arginine; Blood Proteins; Case-Control Studies; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Imidazoles; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Neutrophils; Norleucine; Oxidative Stress; Protein Carbonylation; Pyrroles; Renal Dialysis; Respiratory Burst; Serum Albumin	2005
Arterial stiffness and Chlamydia pneumoniae infection in coronary artery disease. Is there a link? Scandinavian cardiovascular journal : SCJ, 2006, Volume: 40, Issue:5 Topics: Adult; Aged; Arteries; Atorvastatin; Chlamydia Infections; Chlamydophila pneumoniae; Constriction, Pathologic; Coronary Artery Disease; Diabetes Mellitus; Double-Blind Method; Female; Heptanoic Acids; Humans; Immunoglobulin A; Male; Middle Aged; Pyrroles; Risk Factors; Simvastatin; Smoking; Vascular Resistance	2006
Diabetes and residual risk of coronary heart disease. Nature clinical practice. Endocrinology & metabolism, 2007, Volume: 3, Issue:2 Topics: Anticholesteremic Agents; Atorvastatin; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Heptanoic Acids; Humans; Insulin Resistance; Obesity; Pyrroles; Risk Factors; Simvastatin	2007
A novel mechanism of action for statins against diabetes-induced oxidative stress. Diabetologia, 2007, Volume: 50, Issue:4 Topics: Animals; Antioxidants; Aorta; Atorvastatin; Diabetes Complications; Diabetes Mellitus; Endothelial Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Mice; Mice, Inbred C57BL; Oxidative Stress; Polyisoprenyl Phosphates; Pyrroles; rac GTP-Binding Proteins	2007
Economic impacts attributable to the early clinical benefit of atorvastatin therapy--a US managed care perspective. Current medical research and opinion, 2007, Volume: 23, Issue:7 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Coronary Disease; Costs and Cost Analysis; Diabetes Mellitus; Drug Costs; Female; Heptanoic Acids; Humans; Male; Models, Theoretical; Pyrroles; Simvastatin; United States	2007
Lowering LDL-C for optimal protection in high-risk patients. The American journal of managed care, 2008, Volume: 14, Issue:1 Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Guideline Adherence; Heptanoic Acids; Humans; Hypercholesterolemia; Practice Guidelines as Topic; Pravastatin; Pyrroles; Risk Assessment	2008
Enzymatic assays of L-ornithine and L-delta 1-pyrroline-5-carboxylate in tissues, and orniathine-load test in human subjects. Analytical biochemistry, 1980, Jul-15, Volume: 106, Issue:1 Topics: Adolescent; Adult; Animals; Diabetes Mellitus; Female; Fluorometry; Humans; Liver Cirrhosis; Male; Middle Aged; Ornithine; Ornithine-Oxo-Acid Transaminase; Oxidoreductases Acting on CH-NH Group Donors; Pyrroles; Pyrroline Carboxylate Reductases; Rats; Transaminases	1980
Structural relationships between the endogenous volatile urinary metabolites of experimentally diabetic rats and certain neurotoxins (l). Experientia, 1982, Jan-15, Volume: 38, Issue:1 Topics: Animals; Diabetes Mellitus; Diabetic Neuropathies; Gas Chromatography-Mass Spectrometry; Ketones; Male; Methyl n-Butyl Ketone; Neurotoxins; Pyrroles; Rats; Rats, Inbred Strains; Volatilization	1982
Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins. Biochimica et biophysica acta, 1995, Nov-15, Volume: 1253, Issue:1 Topics: Aminocaproates; Arginine; Blood Proteins; Caproates; Chromatography, High Pressure Liquid; Collagen; Cross-Linking Reagents; Crystallins; Diabetes Mellitus; Fluorescence; Glycation End Products, Advanced; Humans; Lysine; Magnetic Resonance Spectroscopy; Maillard Reaction; Mass Spectrometry; Models, Chemical; Proteins; Pyrroles; Ribonuclease, Pancreatic; Spectrophotometry; Tetroses	1995
Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo. Biochimica et biophysica acta, 1995, Feb-22, Volume: 1247, Issue:1 Topics: Animals; Blood Proteins; Cattle; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus; Glucose; Glycosylation; Humans; Magnetic Resonance Spectroscopy; Norleucine; Pyrroles; Serum Albumin, Bovine	1995
Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation. Clinical science (London, England : 1979), 1993, Volume: 84, Issue:1 Topics: Animals; Blood Proteins; Blotting, Western; Cattle; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Fructosamine; Glucose; Glycation End Products, Advanced; Hexosamines; Humans; In Vitro Techniques; Maillard Reaction; Norleucine; Pyrroles; Serum Albumin, Bovine	1993
Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes. Archives of biochemistry and biophysics, 1996, Jan-15, Volume: 325, Issue:2 Topics: Aging; Amino Acids; Animals; Cross-Linking Reagents; Diabetes Mellitus; Ethers; Humans; Magnetic Resonance Spectroscopy; Maillard Reaction; Molecular Structure; Norleucine; Proteins; Pyrroles; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry	1996
The presence of a glucose-derived Maillard reaction product in the human lens. FEBS letters, 1996, Mar-18, Volume: 382, Issue:3 Topics: Animals; Cataract; Cattle; Crystallins; Deoxyglucose; Diabetes Mellitus; Humans; Lens, Crystalline; Maillard Reaction; Norleucine; Protein Conformation; Pyrroles	1996
Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. European journal of pharmacology, 1999, May-21, Volume: 372, Issue:3 Topics: Analysis of Variance; Animals; Capsaicin; Carbazoles; Carcinogens; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus; Enzyme Inhibitors; Hot Temperature; Hyperalgesia; Indoles; Male; Mice; Mice, Inbred ICR; Naphthalenes; Pain; Pain Measurement; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrroles; Spinal Cord	1999
Pleiotropic effects of statins in atherosclerosis and diabetes. Diabetes care, 2000, Volume: 23 Suppl 2 Topics: Animals; Arteriosclerosis; Atorvastatin; Cell Division; Cell Movement; Cells, Cultured; Cholesterol; Cholesterol Esters; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Endocytosis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins; Lovastatin; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Muscle, Smooth; Pyridines; Pyrroles; Simvastatin	2000
Potential interaction between troglitazone and atorvastatin. Journal of clinical pharmacy and therapeutics, 2000, Volume: 25, Issue:4 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Chromans; Diabetes Mellitus; Drug Interactions; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hyperlipidemias; Hypoglycemic Agents; Male; Middle Aged; Pyrroles; Retrospective Studies; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone	2000
Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus. The American journal of cardiology, 2002, Jun-01, Volume: 89, Issue:11 Topics: Atorvastatin; Cholesterol; Delayed-Action Preparations; Diabetes Mellitus; Drug Therapy, Combination; Heptanoic Acids; Humans; Hypolipidemic Agents; Niacin; Pyrroles; Retrospective Studies; Triglycerides	2002
Gas chromatographic-mass spectrometric study of volatile organic metabolites in urines of patients with diabetes mellitus. Journal of chromatography, 1975, Oct-29, Volume: 112 Topics: 1-Propanol; Adsorption; Adult; Aged; Alcohols; Butanols; Butanones; Chromatography, Gas; Cyclohexanones; Diabetes Mellitus; Ethanol; Female; Gas Chromatography-Mass Spectrometry; Humans; Ketones; Male; Mass Screening; Mass Spectrometry; Middle Aged; Molecular Weight; Pentanols; Pyrroles	1975
Specific detection of volatile metabolites in urines of normal subjects and patients with diabetes mellitus using computerized mass fragmentography. Journal of chromatography, 1975, Oct-29, Volume: 112 Topics: 1-Propanol; Adolescent; Adult; Alcohols; Butanols; Chromatography, Gas; Computers; Diabetes Mellitus; Ethanol; Gas Chromatography-Mass Spectrometry; Humans; Ketones; Male; Middle Aged; Pyrroles	1975
[The "in vitro" effect of gliclazide, a new hypoglycemic agent, on normal human blood platelets]. Thrombosis research, 1974, Volume: 4, Issue:4 Topics: Blood Platelets; Carbon Radioisotopes; Cyclopentanes; Diabetes Mellitus; Enzyme Repression; Glycogen; Glycogen Synthase; Humans; Hypoglycemic Agents; In Vitro Techniques; Pyrroles; Sulfonylurea Compounds	1974
[Effect of gliclazide on platelet behavior]. La Nouvelle presse medicale, 1974, Oct-05, Volume: 3, Issue:33 Topics: Adenylyl Cyclases; Blood Glucose; Blood Platelets; Carbon Radioisotopes; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Humans; Hypoglycemic Agents; Platelet Adhesiveness; Pyrroles; Sulfonylurea Compounds; Tritium; Ultracentrifugation	1974
[Gliclazide, a new antidiabetic with hemobiologic and vascular properties]. Lyon medical, 1972, Oct-22, Volume: 228, Issue:16 Topics: Adult; Aged; Cyclopentanes; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrroles; Sulfonylurea Compounds	1972
[The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)]. Therapeutique (La Semaine des hopitaux), 1972, Volume: 48, Issue:9 Topics: Aged; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hypoglycemic Agents; Male; Microcirculation; Middle Aged; Pyrroles; Sex Factors; Sulfonylurea Compounds; Time Factors	1972
[Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity]. Marseille medical, 1972, Volume: 109, Issue:10 Topics: Adult; Aged; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrroles; Sulfonylurea Compounds	1972
Measure of platelet stickiness: the glass beads retention test in animal and human being. Acta Universitatis Carolinae. Medica. Monographia, 1972, Volume: 53 Topics: Animals; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Carotid Arteries; Catheterization; Cyclopentanes; Diabetes Mellitus; Dogs; Drug Evaluation, Preclinical; Femoral Artery; Glass; Guinea Pigs; In Vitro Techniques; Methods; Platelet Adhesiveness; Propionates; Pyrroles; Rabbits; Rats; Salicylates; Species Specificity; Sulfonylurea Compounds; Time Factors; Veins	1972
[Diamicron]. Journees annuelles de diabetologie de l'Hotel-Dieu, 1972, Volume: 13, Issue:0 Topics: Animals; Blood Coagulation; Blood Glucose; Cyclopentanes; Diabetes Mellitus; Humans; Hypoglycemic Agents; Pyrroles; Rats; Sulfonylurea Compounds; Vasomotor System	1972
[A new antidiabetic agent: glyclazide. A study of glycemic regulation]. La Nouvelle presse medicale, 1974, Feb-02, Volume: 3, Issue:5 Topics: Adult; Aged; Blood Glucose; Cyclopentanes; Diabetes Mellitus; Female; Gluconeogenesis; Glycolysis; Glycosuria; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Pyrroles; Statistics as Topic; Sulfonylurea Compounds; Time Factors	1974
Glucosamine acetoacetate condensate. II. Isolation and identification from human diabetic urines. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1969, Volume: 132, Issue:1 Topics: Chromatography, Gas; Diabetes Mellitus; Humans; Infrared Rays; Pyrroles; Spectrophotometry; Spectrum Analysis; Ultraviolet Rays	1969